1 Office of Drug Evaluation 1, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: karen.hicks@fda.hhs.gov.
2 Office of Drug Evaluation 1, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Keywords:
myocardial infarction after coronary revascularization; myocardial infarction related to PCI; periprocedural myocardial infarction; type 4a myocardial infarction.